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SUMMARY
There is a strong relationship between socioeconomic status (SES) and health outcomes in the
United States, although the mechanisms are poorly understood. Increasing evidence points to
links between lifelong exposure to infectious disease and subsequent chronic disease. Exposure
and susceptibility to infections may be one way SES affects long-term health, although little
population-based research to date has examined social patterning of infections in the United
States. This paper tests the relationship between income, education, race/ethnicity and
seroprevalence of cytomegalovirus (CMV) infection at different ages in a representative sample
of the US population, and tests potential mediators for these relationships. The study finds
significant racial and socioeconomic disparities in CMV seroprevalence beginning at early ages
and persisting into middle age. Potential exposures do not explain the relationship between SES
and CMV positivity. Because reactivation of latent CMV infections may contribute to chronic
disease and immune decline later in life, future research should determine the exposure or
susceptibility pathways responsible for these disparities in the prevalence of CMV infection.
INTRODUCTION
Disparities in morbidity and mortality by socio-
economic status (SES) and race/ethnicity in the
United States are well established [1, 2]. The U.S.
Department of Health and Human Services declared
as one of the two major goals of its Healthy People
2010 health promotion agenda ‘to eliminate health
disparities among different segments of the popu-
lation’ [3]. Despite this public concern, the physical
mechanisms underlying health disparities remain
poorly understood. Likely candidates such as health
behaviours and access to health care have not easily
accounted for the gradient [1, 4]. Increasing evidence
points to links between lifelong exposure to infectious
disease and subsequent chronic disease, suggesting
a potential mechanism for linking SES to health
outcomes [5–7]. Low social status has been linked to
increased risk of respiratory infections in humans and
other primates in experimental studies [8–10]. Much
less is known about the links between social status
and susceptibility to infections in the broader US
population.
Exposure to herpesviruses such as cytomegalovirus
(CMV) is nearly ubiquitous in early life, and is even
found in isolated aboriginal groups [11, 12]. Primary
infection during pregnancy is a leading cause of
hearing loss, vision loss, and mental retardation
among congenitally infected children [13]. Although
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infection with CMV often passes undiagnosed be-
cause of its asymptomatic properties, the virus re-
mains persistent in the host’s cells for life. Adequate
cell-mediated immunity is important for maintaining
the virus in this chronic state [14, 15]. Importantly,
CMV has been linked to inflammatory processes,
cardiovascular disease, cognitive outcomes, and
Alzheimer’s disease [11, 16–20]. For these reasons, it
is important to examine the prevalence of CMV at
various life stages within diverse socioeconomic and
racial groups.
Racial/ethnic differences in infection status for
CMV have been described in the United States ad-
justing for SES [12, 13]. Age-adjusted seroprevalence
rates for CMV were found to be 81.7% for Mexican
Americans, 75.8% for non-Hispanic blacks, and
51.2% for non-Hispanic whites [12]. An age-adjusted
association between three categories of family in-
come and CMV seroprevalence was found in the
United States, with this relationship diminishing in
a multivariate model adjusting for age, race/ethnicity,
education, marital status, area of residence, census
region, family size, country of birth, and type of
medical insurance [12]. These studies did not explicitly
examine the relationship between education, income
and prevalence of the infection in different age groups
or test pathways that might explain SES differences in
infection status. This paper will examine differences in
CMV seropositivity by education, income, and race/
ethnicity at different ages, then test whether variables
proxying for potential exposure can explain the re-
lationship between SES, race/ethnicity, and infection
status.
Although previous research has demonstrated
overall socioeconomic and racial/ethnic disparities
in seropositivity, it is unclear at what age social
gradients in infection emerge and what factors might
explain these gradients. There are no studies of which
we are aware that have examined education and in-
come gradients in CMV infection status across age
in a nationally representative sample from the US
population and tested the role of potential exposure
pathways that might explain these differentials. These
are important questions, since the later life conse-
quences of CMV infection for cell-mediated immunity
may depend on the lifetime burden of this infection,
and understanding how socioeconomic and racial/
ethnic groups are differentially exposed and/or sus-
ceptible to this infection can help us design effective
interventions. This paper will examine the relation-
ship between SES, as measured by household income
and years of education, and race/ethnicity, and the
presence of serum IgG antibodies to CMV in persons
aged o6 years in the United States. Looking separ-
ately at children and adults, we will test how well these
disparities can be accounted for by mediating vari-
ables that have been posited as potential exposure risk
factors such as the number of individuals in the
household, nativity outside the United States, region




The National Health and Nutrition Examin-
ation Survey (NHANES) III was conducted by the
National Center for Health Statistics from 1988
to 1994 and was a complex, stratified, multistage
probability cluster sample of the US population
including interview, clinical examination, and lab-
oratory tests. Persons aged <5 years or >60 years,
non-Hispanic black persons, and Mexican Americans
were sampled at a higher frequency than other groups
to obtain adequate sample sizes to more accurately
evaluate these subgroups. The complete methodology
and response rates of NHANES III have been pub-
lished previously [21]. Surplus sera data containing
positive or negative measures for CMV IgG antibody
were released in 2005 for respondents aged o6 years,
thus these data represent the most recent data avail-
able on CMV prevalence in the US population. Our
analysis focuses on two age groups. For ages 6–16
years, 4565/6936 of interviewed respondents also had
information on CMV serostatus and were included in
our analysis. Those missing CMV data were more
likely to be non-Hispanic white, with slightly higher
family income and education of the household refer-
ence person. Another 416 observations in this age
group are omitted due to missing information on
one or more covariates. For ages 25–49 years, of the
8230 interview respondents, 7255 had information
on CMV serostatus. Those missing CMV data were
not significantly different with respect to age, sex,
race, income, or education.Another 1219 observations
were omitted in this age category due to missing
values on one or more covariates. Compared to the
non-missing observations, those omitted were more
likely to be non-Hispanic black, female, and have less
education. All analyses were conducted using Stata
10.0 (Stata Corp., College Station, TX, USA) survey
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commands to account for the complex survey design,
and the sample completing the laboratory compo-
nents was weighted to reflect the non-institutionalized
population of the United States.
Laboratory analyses
Serum samples were tested for CMV specific IgG
with a Triturus robot (Grifols, Miami, FL, USA) with
SeraQuest enzyme-linked immunoabsorbent assay
(ELISA) reagents by Quest International Inc. (Miami,
FL, USA). Reference ranges of positive and negative
controls, and standards were established by the
MLE (Master Lot Entry) card for each lot. ELISA
optical density index values >1.0 were considered
positive.
Sera with values near the ELISA cut-off, between
0.90 and 1.05 (y7% of total), were confirmed with a
second ELISA assay by bioMérieux Inc. (Durham,
NC, USA). When the results from these two tests
disagreed (y2% of total), an IFA from Bion En-
terprises Ltd (Des Plaines, IL, USA) was used and
the result of the IFA was given as the final result.
This procedure resulted in 98% sensitivity and 99%
specificity [12, 22].
Statistical analyses
Logistic regression models were used to test the
relationship between CMV positivity status (0=
negative, 1=positive), race/ethnicity (non-Hispanic
white, Non-Hispanic black, Mexican American, and
Other), years of education, and family income. For
those aged <17 years, education is measured as the
highest grade completed by the household reference
person. For those aged o25 years, education is
measured as the respondent’s years of completed
education. Family income is coded as the midpoint
of each of the 26 reported categories (using $65 000
for incomes>$50 000), adjusted for inflation between
the two NHANES III phases using the consumer
price index. Income was then log-transformed due to
the skewness of the distribution. Variables potentially
mediating exposure included in all models were age
at the time of examination, housing crowdedness
(persons in dwelling/number of rooms), an indicator
for urban or rural residence, census region of resi-
dence, and gender. Results using alternative specifi-
cations of family and household size, including total
number of persons, total number of children, and log
(household size) did not significantly differ from our
measure of housing crowdedness. For respondents
aged <17 years, controls include an indicator for
daycare attendance before the age of 4 years, an in-
dicator for whether the child was born outside
the United States, and an indicator for whether the
child’s mother was born outside the United States.
For respondents aged 25–49 years, age at first sexual
intercourse, an indicator for more than 10 total life-
time sexual partners, and whether the respondent
was born outside the United States are included as
potential exposure mediators. Preliminary models
included continuous measures of number of lifetime
sexual partners, but the dichotomous measure pro-
vided the best fit. To account for potential increased
susceptibility to infections, an indicator for whether
the child was born with low birthweight (<2500 g)
and whether there is a smoker in the home was
included for respondents aged <17 years, and an in-
dicator for current, former or never smoking was
included for adult respondents.
Sexual history questions were not asked of adults
aged >49 years, and thus these adults are included
in the basic analysis represented in Figure 1 but not
included in models testing potential mediators. Due
to concern over measurement of income and edu-
cation for college-age individuals, respondents aged
18–24 years are also included in basic analysis for
Figure 1 but excluded from the full models testing
potential mediators of the relationship between in-
come, education, and CMV seropositivity.
RESULTS
Figure 1 depicts rates of CMV seropositivity by age
for the highest and lowest income quartile in
NHANES III, adjusted for race/ethnicity, rural/




























Fig. 1. Data from the Third National Health and Nutrition
Examination Survey, 1988–1994, showing seroprevalence of
cytomegalovirus (CMV) by age and income quartile.
Results were adjusted for race/ethnicity, rural/urban resi-
dence, census region, sex, and household size. –&–, Top
income quartile ; –m–, bottom income quartile.
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size. We see that cross-sectionally, income differences
in seropositivity appear at early ages, widen in early
and middle adulthood, then converge at older ages as
almost everyone in the population is exposed. Table 1
shows descriptive statistics for our study sample.
Table 2 shows the odds ratios for CMV seropositivity
for ages 6–11 and 12–16 years. The first model esti-
mates the effect of race/ethnicity and household SES
on the odds of CMV seropositivity for children aged
6–11 years without adjustment for potential me-
diators. Adjusting for household SES, non-Hispanic
black children aged 6–11 years have 37% higher
odds of being infected with CMV compared to non-
Hispanic whites, although the confidence interval
includes the null value. Mexican American children
have 93% higher odds of being infected in the 6–11
years age group compared to non-Hispanic whites.
Both education of the reference person and family
income are significantly related to infection status
controlling for race/ethnicity, with each additional
year of education of the family reference person cor-
responding to a 5% decrease in the odds of infection.
Moving from a family income of $15 000 a year to
$40 000 is associated with 14% lower odds of infec-
tion. Next we add controls for markers of potential
exposures and susceptibility. Living in the northeast is
associated with lower odds of infection, while house-
hold crowding and nativity of the mother outside the
United States are significantly related to greater odds
of infection for the 6–11 years age group. Living in a
rural vs. an urban area, daycare attendance, having
a smoker in the household, and being born with
lowbirth weight are not significantly associated with
infection status controlling for other factors. The
addition of these potential mediators eliminates the
racial/ethnic and parental educational differences in
infection status in children aged 6–11 years, while the
differences in CMV seropositivity by income remain
unchanged. For children aged 12–16 years, the results
are similar. Racial/ethnic differences in seropositivity
are eliminated upon inclusion of mediators, but for
older children the differences by both parental edu-
cation and family income remain.
Table 3 presents results for adults aged 25–49 years
separately by sex. Relative differences in sero-
positivity by race/ethnicity in this age range have
greatly increased compared to the childhood sample,
with non-Hispanic black males having almost four
times the odds of infection compared to non-Hispanic
white males, and Mexican American males having
Table 1. Sample descriptive statistics (weighted ) National Health and
Nutrition Examination Survey III, 1988–1994
Ages 6–16 yr Ages 25–49 yr
Cytomegalovirus positive 38.6% 57.1%
Non-Hispanic white 67.7% 76.9%
Non-Hispanic black 14.5% 11.3%
Mexican American 13.4% 5.03%
Male 51.3% 49.1%
Years of education* 12.5 (0.11) 13 (0.08)
Annual family income 36864.5 (1145.7) 41 432 (809)
Housing density (persons/rooms) 0.79 (0.01) 0.61 (0.01)
Before age 4 yr, attend daycare
with o6 children
46% n.a.
Smoker in household 39.1% n.a.
Child born with low birthweight 2.7% n.a.
Mother born outside USA 15.6% n.a.
Born outside USA 7.0% 11.5%
Never smoker n.a. 45%
Former smoker n.a. 21.3%
Current smoker n.a. 33.7%
>10 Lifetime sexual partners n.a. 32.4%
Age at first intercourse (yr) n.a. 17.6 (0.08)
N= 4149 6036
Percentage or mean and linearized standard error.
* Highest grade completed by household reference person for ages 6–16 yr.
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Table 2. Risk factors for cytomegalovirus seropositivity for age <17 years, National Health and Nutrition
Examination Survey III, 1988–1994
Age 6–11 yr (n=2434) Age 12–16 yr (n=1786)
Model 1 Model 2 Model 1 Model 2
Non-Hispanic white 1.0 1.0 1.0 1.0
Non-Hispanic black 1.37 (0.99–1.90) 1.28 (0.93–1.76) 1.27 (0.91–1.77) 1.16 (0.83–1.63)
Mexican American 1.93 (1.41–2.63) 1.14 (0.80–1.65) 1.75 (1.23–2.49) 1.16 (0.76–1.75)
Education of family reference
person
0.95 (0.92–0.98) 0.99 (0.95–1.02) 0.91 (0.88–0.94) 0.93 (0.90–0.97)
Log (family income) 0.86 (0.77–0.96) 0.83 (0.73–0.94) 0.85 (0.77–0.95) 0.86 (0.76–0.96)
Male 1.01 (0.86–1.17) 0.67 (0.56–0.80)
USDA code – rural 1.08 (0.87–1.33) 1.09 (0.84–1.41)
Census region
Northeast 1.0 1.0
Midwest 1.70 (1.09–2.66) 1.01 (0.65–1.56)
South 1.88 (1.27–2.77) 1.50 (1.11–2.04)
West 1.91 (1.25–2.93) 1.43 (0.99–2.05)
Housing density (persons/rooms) 1.31 (1.03–1.66) 1.34 (1.02–1.77)
Before age 4 yr, attend daycare with
o6 children
1.05 (0.85–1.31) 1.17 (0.94–1.46)
Smoker in the household 0.83 (0.68–1.02) 1.17 (0.97–1.40)
Child born with low birthweight 1.29 (0.96–1.74) 0.65 (0.30–1.44)
Born outside USA 1.44 (0.88–2.34) 2.29 (1.56–3.37)
Mother born outside USA 2.40 (1.75–3.31) 1.79 (1.29–2.49)
Values are odds ratio (95% confidence interval).
All models also control for age in months.
Table 3. Risk factors for cytomegalovirus seropositivity ages 25–49 years, National Health and Nutrition
Examination Survey III, 1988–1994
Males 25–49 yr (n=2710) Females 25–49 yr (n=3326)
Model 1 Model 2 Model 1 Model 2
Non-Hispanic white 1.0 1.0 1.0 1.0
Non-Hispanic black 3.88 (3.06–4.91) 2.72 (1.98–3.73) 5.81 (4.49–7.52) 4.73 (3.51–6.38)
Mexican Americans 4.73 (3.60–6.20) 2.27 (1.64–3.15) 5.67 (3.86–8.32) 3.93 (2.48–6.20)
Years of completed education 0.90 (0.85–0.95) 0.90 (0.84–0.96) 0.88 (0.84–0.93) 0.93 (0.89–0.98)
Log (family income) 0.73 (0.59–0.91) 0.67 (0.53–0.84) 0.79 (0.66–0.93) 0.83 (0.70–0.99)
USDA code – rural 0.91 (0.69–1.18) 0.88 (0.66–1.16)
Census region
Northeast 1.0 1.0
Midwest 1.12 (0.69–1.82) 1.32 (0.96–1.81)
South 2.0 (1.48–2.70) 2.32 (1.55–3.49)
West 1.07 (0.70–1.62) 1.16 (0.74–1.83)
Housing density (persons/rooms) 1.40 (0.96–2.05) 1.62 (0.99–2.64)
Former smoker 0.77 (0.52–1.12) 1.15 (0.79–1.67)
Current smoker 0.64 (0.46–0.91) 1.51 (1.06–2.14)
Born outside USA 6.40 (3.48–11.78) 8.04 (3.66–17.66)
>10 Lifetime sexual partners 1.33 (0.91–1.93) 1.62 (1.19–2.20)
Age at first sexual intercourse 0.98 (0.94–1.02) 0.93 (0.88–0.98)
Values are odds ratio (95% confidence interval).
All models also adjusted for age in years.
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almost five times the odds of infection. The differences
are even larger for females. Differences in infection
status by education and income are also larger
than the gaps at younger ages. Including controls for
potential exposure, we see that being born outside the
United States is a large, positive predictor of infection
status in adults. Living in the south is also associated
with higher odds of infection for both males and fe-
males. Population-based studies have suggested that
sexual transmission is a likely risk factor for exposure
to CMV [12, 23]. Age at first intercourse and having
more than ten lifetimes sexual partners are significant
predictors of CMV infection status only for females.
Household size and rural vs. urban residence are not
associated with seropositivity in adults. Smoking is
associated with a decrease in some immune markers,
and thus may increase susceptibility to infection [24].
Interestingly, being a current smoker is significantly
associated with infection status for both males and
females, but in opposite directions. In fully adjusted
models, smoking raises the odds of seropositivity for
females, while being a current smoker is associated
with a lower risk of seropositivity for males. With
very little literature on the correlates of CMV infec-
tion in the general population, it is difficult to specu-
late as to the reasons behind these different results
for smoking by gender. In models adjusted only for
age, smoking remains positively associated with CMV
infection for females but is not associated with CMV
infection for males. Social factors related to smoking
behaviour may differ by gender. If this is true, then
even controlling for social factors associated with
smoking such as race, income, and education, there
may be residual unmeasured social factors associated
with smoking that are also associated with the likeli-
hood of CMV infection, and these factors may differ
by gender. While racial/ethnic differences in positivity
diminish slightly upon inclusion of controls for
foreign-born status, region of residence, and sexual
behaviours, they remain large. Importantly, income
and education differentials were not explained by ex-
posures commonly cited as risk factors for CMV.
DISCUSSION
This study represents a potential new direction for
researchers investigating the biophysical mechanisms
connecting SES and health outcomes. Numerous
studies have documented an inverse association
between SES and several chronic inflammation-
associated conditions such as cardiovascular disease
and dementia [25–28]. The biological pathways that
mediate these relationships have not been thoroughly
characterized. The social gradient in cardiovascular
disease persists even after adjustment for health be-
haviours and many clinical indicators, suggesting that
other processes may be involved [4, 29]. It is possible
that latent infections such as CMV may explain some
of the socioeconomic gradients in cardiovascular dis-
ease and possibly other inflammatory-associated con-
ditions. Recent research findings have shown that
latent CMV infection in the elderly is an important
component of a set of immunological parameters des-
ignated the ‘ immunological risk phenotype’ [30].
This set of immunological markers, including latent
CMV infection, high CD8 cells, low CD4 cell per-
centages, poor T-cell proliferation, is predictive of
mortality among healthy elderly individuals [31, 32].
While a definitive inference cannot be made based on
cross-sectional data, the results of this study suggest
that individuals with less education, lower income,
and non-white race may spend a larger number of
years infected with CMV on average by the time they
reach older ages. Since the price paid for constant
CMV immune vigilance may be high [33], early life
disparities in CMV infection could have important
implications for disparities in adult health.
Several studies have used herpesviruses, including
CMV, as a marker of immune response to psycho-
social stress exposures [34]. Specifically, increases
in herpesvirus antibody titres have been linked
to academic stress in medical students and military
cadets [35], caregiving for a family member with
Alzheimer’s disease [36], involvement in a poor
quality marriage [37], anticipation of space flight by
astronauts [38], traumatic life events [39], as well as
psychological traits of loneliness and anxiety [40]. It
is less clear, however, what role stress may play in
initial susceptibility to CMV. Data examining respir-
atory infections have reported a relationship between
low SES, increased levels of stress, and enhanced
susceptibility to several cold and flu viruses [9, 10, 41].
Low social class was associated with lower secretory
immunoglobulin (sIgA), cited as a first line of defence
against infection, in a large community sample in
Scotland [24]. Taken together, these studies suggest
that psychological stress associated with low SES
can down-regulate various aspects of the cellular
immune response, increasing susceptibility to infec-
tion. A recent study reported an association between
levels of antibody to CMV and level of education in
a sample of elderly Latinos [42]. While measures of
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psychosocial stress are not available in the NHANES
III data, further studies are needed to assess whether
stress mediates the relationship between socio-
economic and race/ethnic differences in CMV sus-
ceptibility and antibody response.
There are several limitations to the current study.
First, while our analysis has controlled for several
exposure variables available in the data such as
housing crowdedness, daycare attendance, and num-
ber of sexual partners, these variables are probably
measured with error. For example, underreporting of
the number of sexual partners is probable due to the
sensitive nature of the question. Housing crowdedness
and family size are imperfect measures of the trans-
mission dynamics that actually determine an in-
dividual’s risk of exposure. Being HIV positive or
being otherwise immunocompromised would increase
one’s susceptibility to CMV infection, but this infor-
mation is not available in our data. It is unlikely that
these factors explain the differences in seropositivity
status seen at early ages. Nonetheless, it is difficult to
determine the importance of unmeasured exposures
vs. susceptibility characteristics in explaining the
socioeconomic and racial/ethnic differences in CMV
seropositivity. Since the NHANES III data are cross-
sectional, we are also not capturing new infections
as we look across age groups, but are rather trying
to explain differences in prevalence of this infection
that could have been acquired at any age prior to
measurement. Potential explanatory variables such
as sexual behaviours are unlikely to explain CMV
infections that were acquired in childhood. Since
the seroprevalence rate for the overall 6–11 years
age group is already 36.3%, there are important pre-
dictors of group differences in infection status that are
potentially found in unmeasured early life exposures,
especially parental or sibling risk factors. Another
limitation is that while these are the most recent data
available on CMV prevalence in the US population,
this sample consists of respondents surveyed from
1988 to 1994, and thus might be less representative of
the current social patterning of CMV infection in the
United States.
In conclusion, we find socioeconomic and racial/
ethnic disparities in CMV infection in the US popu-
lation that are evident as early as age 6 years and
persist through middle age. These differentials were
not easily explained by exposures commonly cited as
risk factors for CMV. Differences in lifelong exposure
to persistent infections such as CMV may be one way
in which lower social status contributes to poorer
health outcomes. Future research should examine the
exposure or susceptibility pathways responsible for
these disparities in the prevalence of CMV infection.
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